Ubrelvy 100 MG tablet UD 16S
Ended Awarded
- Contract number
- SPE2DB26FAAR2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,086
Award facts
- Contract value 100% obligated
- $66,086.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $66,086.19, for the supply of Ubrelvy 100 mg tablets (unit dose, 16 count) on October 27, 2025, with an ultimate completion date of October 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ubrelvy is a prescription medication used in the treatment of acute migraines, reflecting the Defense Logistics Agency's role in supplying pharmaceutical products to support military and federal healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying an extensive portfolio of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The contractor's demonstrated capability to fulfill competitive federal procurement requirements across multiple therapeutic domains and order values positions it as a key supplier within the DLA's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB26FAAR2?
SPE2DB26FAAR2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FAAR2 worth?
The government has obligated $66,086 on SPE2DB26FAAR2.
Is contract SPE2DB26FAAR2 an order under another contract?
Yes. SPE2DB26FAAR2 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB26FAAR2 competed?
The extent of competition for SPE2DB26FAAR2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award